Literature DB >> 6257522

Quantitation of thyroidal binding of iodide by compartmental analysis verified by an intravenous perchlorate discharge test.

T E Hilditch, P W Horton, W D Alexander.   

Abstract

Compartmental analysis was applied to 123I-iodide uptake data to quantitate iodine binding in the human thyroid gland. The method allowed for arterio/venous differences in plasma tracer level and for an "instantaneous" phase of thyroid uptake. Results were checked by an intravenous perchlorate discharge test. Observations in eleven normal and untreated thyrotoxic subjects confirmed earlier findings that iodine binding takes place rapidly, the binding rate constant being much greater than the exit rate constant. A lower limit of 0.15 min-1 for the binding rate constant in the uninhibited gland was estimated from the observations in one subject who demonstrated a small perchlorate discharge. The method was used in the study of eight subjects with an intrinsic binding defect and of twenty-four thyrotoxic subjects being treated with 5 mg or 20 mg carbimazole, twice daily. Binding rate constants (range 0.003--0.105 min-1) were typically less than the exit rate constants (range 0.027--0.156 min-1), the net clearance of iodide ranging from 1.5 to 67.9% of the unidirectioinal clearance, compared to 72% in the uninhibited gland. The method proved useful in assessing the severity of an intrinsic binding defect and in the investigation of lack of response to antithyroid drug therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6257522     DOI: 10.1007/bf00252040

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  Studies on radioiodine treatment of thyrotoxicosis; with special reference to the behaviour of the radioiodine tracer tests.

Authors:  L G LARSSON
Journal:  Acta Radiol Suppl       Date:  1955

2.  Simultaneous measurement of the iodide-concentrating and protein-binding capacities of the normal and hyperfunctioning human thyroid gland.

Authors:  S H INGBAR
Journal:  J Clin Endocrinol Metab       Date:  1955-02       Impact factor: 5.958

3.  The iodide trapping and binding functions of the thyroid.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

4.  Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs.

Authors:  P W Horton; W T Millar; D G McLarty; W D Alexander
Journal:  Clin Endocrinol (Oxf)       Date:  1975-07       Impact factor: 3.478

5.  Red-cell lifetimes calculated from 51Cr red-cell survival data.

Authors:  J C Widman; E R Powsner
Journal:  Med Phys       Date:  1974 Mar-Apr       Impact factor: 4.071

6.  A twenty minute perchlorate discharge test.

Authors:  H W Gray; L A Hooper; W R Greig; I R McDougall
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

7.  Minimum effective dose of carbimazole.

Authors:  L C Low; T E Hilditch; W D Alexander
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

8.  Kinetics of the human thyroid trap: a compartmental model.

Authors:  M T Hays
Journal:  J Nucl Med       Date:  1978-07       Impact factor: 10.057

9.  Use of I-123 in early radioiodide uptake and its suppression in children and adolescents with hyperthyroidism.

Authors:  W N Lee; P D Mpanias; R J Wimmer; M A Greenfield; S A Kaplan
Journal:  J Nucl Med       Date:  1978-09       Impact factor: 10.057

10.  Unexpected differences in early thyroidal trapping of iodide and pertechnetate.

Authors:  T E Hilditch; W D Alexander
Journal:  Eur J Nucl Med       Date:  1980-04
View more
  2 in total

1.  Early kinetics of the human thyroid trap estimated with 99mTc and 131I.

Authors:  P Fragu; J P Bazin; R Di Paola; M Tubiana
Journal:  Eur J Nucl Med       Date:  1982

2.  Intrathyroidal iodide binding rates and plasma methimazole concentrations in hyperthyroid patients on small doses of carbimazole.

Authors:  L C Low; D C McCruden; W D Alexander; T E Hilditch; G G Skellern; B I Knight
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.